Book now
Current Sponsors
Fund Sponsors
Panel Sponsors
Exhibitors
Polar Capital was established in January 2001 as a research driven investment management company providing a highly entrepreneurial environment for portfolio managers, within a structure that offers full marketing, administrative and operational support.
Today Polar Capital has a staff of 50 of whom 22 are investment professionals managing nine funds and nine managed accounts. These funds, which are aimed at institutional and professional investors, have combined assets under management as at 30 June 2010 of US$2.6bn.
Bank of America is one of the world's largest financial institutions, serving large corporations, small- and middle-market businesses and individual consumers in more than 150 countries with a full range of banking, investing, asset management and other financial and risk management products and services. Bank of America Corporation stock (NYSE: BAC) is a component of the Dow Jones Industrial Average and is listed on the New York Stock Exchange.
Bank of America Merrill Lynch represents the global banking and markets businesses of Bank of America and is a global leader in corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. The company provides, through various banking and broker-dealer affiliates, M&A advice, equity and debt capital raising solutions, lending, risk management, treasury, liquidity, and payments management.
The Bank of America Merrill Lynch INVEST group is a leading and fully integrated global multi asset platform, providing clients with innovative investment solutions through our market leading expertise in the Structured Products and UCITS Funds space.
Boston BioCom is a biomedical technology commercialization company created to
earn superior returns by actively developing and managing a hand-picked
portfolio of biomedical innovations. We bring together pre-eminent academic
expertise, industry-leading pharmaceutical capabilities, and a highly
experienced management team to create value from an extraordinary flow of
technology opportunities.
In March 2008 Pfizer Inc. provided the initial $10 million of capital, as they
were impressed with the synergies available. We benefit from the valuable
experience of Pfizer in many research areas.
Fund Management Group (FMG), launched in 1989 as a specialist family office fund of funds, FMG has evolved into a highly regarded specialist in emerging markets, particularly Russia, India, China, MENA & Africa. The investment group established the first Russian fund of funds in 1995. In 2003, FMG launched its Rising 3 fund which focuses on a variety of equity managers in Russia, India and China. The success of Rising 3 led to the group's creation of several new frontier funds, including MENA in 2006 and sub-Saharan Africa in 2007. June 2010, saw the launch of the FMG Iraq fund.
FMG remains committed to achieving higher risk-adjusted returns from its selective base of managers.
Recent Ratings and Awards:-
Morningstar – Rates the FMG Rising 3 Fund as the top performer among its peers in 2009.
MENA Fund Manager Magazine, FMG MENA Fund, Winner for Fund of Funds of the Year 2009.
